Sorrento Therapeutics | 8-K: Current report
Nov 8, 2023 05:34
Sorrento Therapeutics | 8-K: Current report
Nov 4, 2023 05:31
Sorrento Therapeutics | 8-K: Current report
Oct 28, 2023 04:15
Sorrento Therapeutics | 8-K: Current report
Oct 6, 2023 05:26
Sorrento Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(2.6%)
Oct 6, 2023 05:22
Sorrento Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Sorrento Therapeutics, Inc.
Oct 6, 2023 05:16
Sorrento Therapeutics | 8-K: Current report
Sep 27, 2023 04:54
Sorrento Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(1.3%)
Sep 27, 2023 04:49
Sorrento Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Sorrento Therapeutics, Inc.
Sep 26, 2023 04:27
Sorrento Therapeutics | 8-K: Current report
Sep 13, 2023 09:51
Sorrento Therapeutics | 8-K: Current report
Aug 29, 2023 05:25
Sorrento Therapeutics | 8-K: Current report
Aug 21, 2023 23:20
Sorrento Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(43.3%)
Aug 15, 2023 08:59
Sorrento Therapeutics | 10-Q: Q2 2023 Earnings Report
Aug 12, 2023 08:00
Sorrento Therapeutics | 8-K: Current report
Aug 11, 2023 04:14
Sorrento Therapeutics | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Aug 8, 2023 04:15
Sorrento Therapeutics | 8-K: Current report
Aug 1, 2023 18:01
Sorrento Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Jul 19, 2023 05:23
Sorrento Therapeutics | 8-K: Current report
Jul 13, 2023 18:26
Sorrento Therapeutics | 8-K: Current report
Jul 8, 2023 09:49
No Data
No Data